Lacosamide Tablet
Product Images NDC 27808-244

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 27808-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tris Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Str (Lacosamide Tablets Usp 1)

Chemical structure of lacosamide, showing its molecular arrangement with functional groups including acetyl, amide, ether linkages, and a benzyl substituent. The diagram displays formula components with carbon, hydrogen, oxygen, and nitrogen atoms as part of the structure.*

FDA Label Image

Fig1 (Lacosamide Tablets Usp 2)

A bar chart showing median percent seizure reduction from baseline in three studies (Study 2, Study 3, and Study 4) comparing placebo and Lacosamide tablets at different dosages (200, 400, and 600 mg/day). Each study presents seizure reduction percentages for placebo and Lacosamide doses, with Lacosamide treatments showing higher seizure reduction compared to placebo, some with statistical significance.*

FDA Label Image

Fig2 (Lacosamide Tablets Usp 3)

A responder rate graph depicting patient improvement or worsening rates versus percent of patients for placebo and Lacosamide Tablets at doses of 200 mg/day, 400 mg/day, and 600 mg/day. The graph includes lines for placebo and each dosage level, showing response trends among the study population sizes.*

FDA Label Image

50mglabel (Lacosamide Tablets Usp 4)

Lacosamide Tablets, USP oral tablets, 50 mg strength, packaged by Tris Pharma Inc. The label indicates 60 tablets per container and includes storage instructions (20° to 25°C, with permitted excursions). The product is manufactured by Indoco Remedies Ltd. The NDC number is 27808-243-01.*

FDA Label Image

100mg Label (Lacosamide Tablets Usp 5)

Label for Lacosamide Tablets, USP 100 mg oral tablets, manufactured for Tris Pharma Inc. The label states 60 tablets per bottle, includes the NDC 27808-244-01, and provides storage instructions at 20° to 25°C. It also notes that each tablet contains 100 mg Lacosamide and directs pharmacists to provide the accompanying Medication Guide.*

FDA Label Image

150mg Label (Lacosamide Tablets Usp 6)

Label for Lacosamide Tablets, USP 150 mg oral tablets in a 60-tablet package. The label includes storage instructions, a note for pharmacists about medication guides, barcodes, and manufacturer information indicating manufacture by Indoco Remedies Ltd. and labeling by Tris Pharma Inc.*

FDA Label Image

200mg Label (Lacosamide Tablets Usp 7)

Lacosamide Tablets, USP 200 mg oral tablets label showing a quantity of 60 tablets. The label includes storage instructions (20 to 25°C with excursions permitted between 15 to 30°C), a barcode, and manufacturer information for Indoco Remedies Ltd. The labeler is Tris Pharma Inc. It states the product is prescription only and includes a pharmacist advisory to provide the medication guide to patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.